Your browser doesn't support javascript.
loading
Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke.
Vahidy, Farhaan S; Donnelly, John P; McCullough, Louise D; Tyson, Jon E; Miller, Charles C; Boehme, Amelia K; Savitz, Sean I; Albright, Karen C.
Afiliação
  • Vahidy FS; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Donnelly JP; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • McCullough LD; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Tyson JE; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Miller CC; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Boehme AK; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Savitz SI; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
  • Albright KC; From the Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston (F.S.V., L.D.M., S.I.S.); Department of Emergency Medicine (J.P.D.) and Department of Neurology (K.C.A.), University of Alabama School of Medicine, Birmingham; Center for Clinical Research a
Stroke ; 48(5): 1386-1388, 2017 05.
Article em En | MEDLINE | ID: mdl-28389607
ABSTRACT
BACKGROUND AND

PURPOSE:

Readmission within 30 days of hospital discharge for ischemic stroke is an important quality of care metric. We aimed to provide nationwide estimates of 30-day readmission in the United States, describe important reasons for readmission, and sought to explore factors associated with 30-day readmission, particularly the association with recanalization therapy.

METHODS:

We conducted a weighted analysis of the 2013 Nationwide Readmission Database to represent all US hospitalizations. Adult patients with acute ischemic stroke including those who received intravenous tissue-type plasminogen activator and intra-arterial therapy were identified using International Classification of Diseases-Ninth Revision codes. Readmissions were defined as any readmission during the 30-day post-index hospitalization discharge period for the eligible patient population. Proportions and 95% confidence intervals for overall 30-day readmissions and for unplanned and potentially preventable readmissions are reported. Survey design logistic regression models were fit for determining crude and adjusted odds ratios and 95% confidence interval for association between recanalization therapy and 30-day readmission.

RESULTS:

Of the 319 317 patients with acute ischemic stroke, 12.1% (95% confidence interval, 11.9-12.3) were readmitted. Of these, 89.6% were unplanned and 12.9% were potentially preventable. More than 20% of all readmissions were attributable to acute cerebrovascular disease. Readmitted patients were older and had a higher comorbidity burden. After controlling for age, sex, insurance status, and comorbidities, patients who underwent recanalization therapy had significantly lower odds of 30-day readmission (odds ratio, 0.82; 95% confidence interval, 0.77-0.89).

CONCLUSIONS:

Up to 12% of patients with ischemic stroke get readmitted within 30 days post-discharge period, and recanalization therapy is associated with 11% to 23% lower odds of 30-day readmission.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Procedimentos Cirúrgicos Vasculares / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Readmissão do Paciente / Procedimentos Cirúrgicos Vasculares / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article